Tetrahydrobiopterin, the cofactor for tyrosine hydroxylase and other monooxygenases, is present in tissues at apparent concentrations much less than those necessary to saturate the corresponding enzymes. Reserpine treatment or insulininduced hypoglycemia in rats produces a statistically significant increase in the tetrahydrobiopterin content of both the adrenal medulla and the cortex. Adrenal denervation and hypophysectomy selectively block the increases in cofactor level in medulla and cortex, respectively, while cycloheximide prevents the increase in both tissues. Reserpine did not increase cofactor levels in liver, kidney, or corpus striatum but decreased that of the pineal gland. These results suggest that tetrahydrobiopterin is under neural control in the medulla and hormonal control in the cortex and that increases in cofactor may result from induction ofenzyme(s) in the biosynthetic pathway. These results demonstrate regulation of tissue tetrahydrobiopterin and are consistent with the suggestion that cofactor levels participate in the regulation of tyrosine hydroxylase in the adrenal medulla and may have a function, as yet undetermined, in the adrenal cortex.L-erythro-5,6,7,8-tetrahydrobiopterin (H4B) is an essential cofactor for tyrosine 3-monooxygenase [TyrOase; tyrosine hydroxylase; L-tyrosine, tetrahydropteridine:oxygen oxido reductase (3-hydroxylating); EC 1.14.16.2] (1), the rate-limiting enzyme in the biosynthesis ofthe neurotransmitters dopamine, norepinephrine, and epinephrine (2). There is considerable evidence for the short-term regulation oftyrosine hydroxylation by a decrease in the Km of TyrOase for its cofactor, H4B (for recent reviews, see refs. 3 and 4). Delayed or long-term regulation of tyrosine hydroxylation and catecholamine synthesis is obtained by increased synthesis ofTyrOase, dopamine-,B-hydroxylase, and catecholamine storage vesicles (5, 6). Several lines of evidence suggest that H4B is present in concentrations substantially less than Km for TyrOase in monoaminergic neurons. The administration of exogenous cofactor results in enhanced hydroxylation in rat striatum in vivo (7), in cultures of sympathetic neurons (8), in striatal synaptosomes (9), and in the isolated hypogastric nerve-vas deferens preparation (10, 11). A second line of evidence is the increase in dopamine synthesis produced by cyclic AMP or stimulation of catecholaminergic terminals that apparently is the result of the increased affnity of TyrOase for the pterin cofactor (12-15). Finally, induction ofrat hypothalamus TyrOase by reserpine administration failed to enhance tyrosine hydroxylation in synaptosomes prepared from this tissue (16) unless exogenous H4B was added to the incubation medium (17). Although regulation of monoamine synthesis through changes in the availability of reduced biopterin has been proposed (18), there is no experimental evidence for physiological regulation of endogenous cofactor levels. The long-term regulation of catecholamine synthesis could create a paradoxical situation if t...